Dipna Pharmachem Ltd
₹4.06▲ +0.09 (+2.27%)
DPL·BSE·Healthcare
Market Cap
10.67 Cr
PE Ratio
4.06
Volume
12,000
Day High - Low
4.09 - 4.05
52W High-Low
20.50 - 3.89
₹4.06▲ +0.09 (+2.27%)
Market Cap10.67 Cr
PE Ratio4.06
Volume12,000
Day High - Low4.09 - 4.05
52W High-Low20.50 - 3.89
Dipna Pharmachem Ltd (DPL): company summary
The company's annual revenue grew 3.3% to ₹129 crore, but the latest quarter's revenue fell 87.3% year-on-year to ₹2 crore.
Dipna Pharmachem Ltd (DPL) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Dipna Pharmachem Ltd last traded at ₹4.06, up 2.27% on the day.
- Recent developments
- On 2026-06-30, promoter holding was recorded at 9.13%, with no changes noted in foreign or domestic institutional holdings. The latest quarter ended on 2026-03-31, showing a sharp decline in revenue and net profit compared to the same period last year.
- Financial performance
- The company's annual revenue grew 3.3% to ₹129 crore, but the latest quarter's revenue fell 87.3% year-on-year to ₹2 crore. Net profit surged 171.1% annually to ₹3 crore, but the latest quarter's net profit was ₹0 crore, down 64.0% from the same quarter a year earlier. The net profit margin improved to 2.0% from 0.8%.
- Valuation multiples
- The stock trades at 4.1 times earnings, a discount to the Healthcare median of 32.0, 0.20 times book value.
- Things to watch
- The latest quarter's revenue and net profit dropped significantly, with revenue falling 87.3% and net profit remaining at ₹0 crore. The company's market cap is ₹10 crore, and the stock is 81.4% below its 52-week high. The latest quarter's net profit margin was flat at 0.0%.
- Where it stands
- Dipna Pharmachem Ltd's annual net profit rose sharply, but the latest quarter's results show a steep decline. The stock is far below its 52-week high, and the latest quarter's revenue and net profit were both down significantly from the same period last year. The company's market cap remains small at ₹10 crore.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.4/10
Weak
Fair Value
Sign in to see
ROE
4.22%
Weak
P/E
4.06x
Cheap
Debt / Equity
0.21
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹4.05
₹4.09
52W₹3.89
₹20.50
DocStoX take
Supported by valuation (9.0) and growth (8.5), but held back by momentum (0.0). Valuation looks strong at 9.0, but that is offset by momentum at 0.0 and quality at 2.2. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.4
/10
Weak
Quality
Weak
ROE 4.2%
Valuation
Cheap
P/E 4.1×
Growth
Strong
Revenue +33.0% 5Y CAGR
Risk
Moderate
D/E 0.21
Momentum
Weak
1% of 52-week range
At a glance
Market Cap
₹11 Cr
52W High / Low
₹21 / ₹4
Dividend Yield
0.00%
Promoter Holding
9.13%
EPS (TTM)
₹1.00
Book Value
₹23.70
Key highlights
- Profit compounding 42% a year
- Revenue compounding 33% a year
- Low leverage — D/E 0.21
- Quality is weak (2.2/10)
- Momentum is weak (0.0/10)
4 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Dipna Pharmachem Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Dipna Pharmachem Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Dipna Pharmachem Ltd with peers
Dipna Pharmachem Ltd vs Sun Pharmaceutical Industries LimitedDipna Pharmachem Ltd vs Divi's Laboratories LimitedDipna Pharmachem Ltd vs Torrent Pharmaceuticals LimitedDipna Pharmachem Ltd vs Laurus Labs LimitedDipna Pharmachem Ltd vs Zydus Lifesciences LimitedDipna Pharmachem Ltd vs Apollo Hospitals Enterprise Limited
Related tools & concepts
Value Dipna Pharmachem Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing